HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
KIDS
OrthoPediatrics Corp.
KIDS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
KIDS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Unavailable |
KIDS's revenue is currently healthy, and its cash flow is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
KIDS PE Valuation
KIDS has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
KIDS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
KIDS has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over KIDS on earnings, with more consistent year-over-year improvement.
KIDS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.43 | +$0.53 |
| Q2 2026 | -$1.68 | +$0.12 |
| Q1 2026 | -$1.68 | +$0.08 |
| Q4 2025 | -$1.69 | -$0.05 |
| Q3 2025 | -$1.96 | -$0.73 |
| Q2 2025 | -$1.80 | -$0.71 |
| Q1 2025 | -$1.76 | -$0.80 |
| Q4 2024 | -$1.64 | -$0.72 |
KIDS is still losing money, but less than at its worst: $1.43 per share over the past year, against $2.05 at its worst in early 2021.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over KIDS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
KIDS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $72.7M | +19% |
| Q2 2026 | $70.5M | +15% |
| Q1 2026 | $59.4M | +13% |
| Q4 2025 | $61.6M | +17% |
| Q3 2025 | $61.3M | +12% |
| Q2 2025 | $61.1M | +16% |
| Q1 2025 | $52.4M | +17% |
| Q4 2024 | $52.7M | +40% |
KIDS's revenue has grown year over year for 23 quarters in a row: $73M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.8% | +9.6 points |
| Q2 2026 | -5.8% | +12 points |
| Q1 2026 | -14% | +6.9 points |
| Q4 2025 | -13% | +13 points |
| Q3 2025 | -15% | -5.2 points |
| Q2 2025 | -17% | -6.7 points |
| Q1 2025 | -21% | +0.8 points |
| Q4 2024 | -27% | -5.3 points |
KIDS has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
KIDS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6M | +$5M |
| Q2 2026 | -$3.1M | +$10.8M |
| Q1 2026 | -$5M | +$3.3M |
| Q4 2025 | $9.7M | +$13.5M |
| Q3 2025 | -$3.4M | +$8.2M |
| Q2 2025 | -$13.9M | -$1.1M |
| Q1 2025 | -$8.4M | +$4.8M |
| Q4 2024 | -$3.7M | +$7.7M |
KIDS's free cash flow has turned positive after six years mostly in the red: $3M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over KIDS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
KIDS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +105K shares |
| 1 year | +2.5% | +588K shares |
| 3 years | +6.1% | +1.4M shares |
| 5 years | +25% | +4.9M shares |
| Available history | +65% | +9.5M shares |
KIDS has 24M diluted shares, up 2.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q1 2020 | $187,000 |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
KIDS Net Leverage
KIDS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
KIDS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.2 | Overbought |
| Stochastic | 84.8 | Overbought |
KIDS's weekly RSI is 78 (overbought) and its Stochastic is 85 (overbought).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
KIDS PE vs Healthcare Sector
| Metric | KIDS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
KIDS has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
KIDS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 25% above |
| 20 week MA | $23.5 | 39% above |
| 50 week MA | $19.9 | 64% above |
| 100 week MA | $20.6 | 58% above |
| 200 week MA | $27.3 | 19% above |
KIDS has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
KIDS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.5 | $46.3 | -0.4% |
| 2021 | $46.3 | $60.8 | +31% |
| 2022 | $60.8 | $38.0 | -37% |
| 2023 | $38.0 | $32.5 | -14% |
| 2024 | $32.5 | $22.9 | -30% |
| 2025 | $22.9 | $17.3 | -24% |
| 2026 YTD | $17.3 | $32.6 | +88% |
KIDS has the edge over HIMS on returns for 2026, with the stronger performance.